Your browser doesn't support javascript.
loading
The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
Hydes, Theresa J; Cuthbertson, Daniel J; Graef, Suzanne; Berhane, Sarah; Teng, Mabel; Skowronska, Anna; Singh, Pushpa; Dhanaraj, Sofi; Tahrani, Abd; Johnson, Philip J.
Afiliação
  • Hydes TJ; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Department of Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom. Electronic address: theresa.hydes@liverpool.
  • Cuthbertson DJ; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom; Department of Medicine, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
  • Graef S; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Berhane S; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, UK; Institute of Applied Health Research, University of Birmingham, UK.
  • Teng M; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Skowronska A; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Singh P; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Dhanaraj S; Department of Liver, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
  • Tahrani A; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Johnson PJ; School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
Clin Ther ; 44(2): 257-268, 2022 02.
Article em En | MEDLINE | ID: mdl-35078642
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Neoplasias Hepáticas / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Clin Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus Tipo 2 / Neoplasias Hepáticas / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: Clin Ther Ano de publicação: 2022 Tipo de documento: Article